Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

IDEX Biometrics

BATS-CHIXE:IDEXO
Snowflake Description

Adequate balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
IDEXO
BATS-CHIXE
NOK666M
Market Cap
  1. Home
  2. GB
  3. Tech
Company description

IDEX Biometrics ASA develops and sells fingerprint imaging and recognition technology in Europe, the Middle East, Africa, the Americas, and Asia. The last earnings update was 41 days ago. More info.


Add to Portfolio Compare Print
  • IDEX Biometrics has significant price volatility in the past 3 months.
IDEXO Share Price and Events
7 Day Returns
19.5%
BATS-CHIXE:IDEXO
0%
GB Electronic
1.7%
GB Market
1 Year Returns
-77.3%
BATS-CHIXE:IDEXO
-5.1%
GB Electronic
-21.8%
GB Market
IDEXO Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
IDEX Biometrics (IDEXO) 19.5% 29.6% -27% -77.3% -88% -
GB Electronic 0% -5.2% -14.2% -5.1% 23.9% 64.7%
GB Market 1.7% -12% -25.3% -21.8% -22.8% -22.4%
1 Year Return vs Industry and Market
  • IDEXO underperformed the Electronic industry which returned -5.1% over the past year.
  • IDEXO underperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -21.8% over the past year.
Price Volatility
IDEXO
Industry
5yr Volatility vs Market

IDEXO Value

 Is IDEX Biometrics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for IDEX Biometrics. This is due to cash flow or dividend data being unavailable. The share price is NOK0.84.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for IDEX Biometrics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are IDEX Biometrics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:IDEXO PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in NOK NOK-0.47
OB:IDEX Share Price ** OB (2020-04-07) in NOK NOK0.93
United Kingdom of Great Britain and Northern Ireland Electronic Industry PE Ratio Median Figure of 22 Publicly-Listed Electronic Companies 17.39x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 13x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of IDEX Biometrics.

BATS-CHIXE:IDEXO PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OB:IDEX Share Price ÷ EPS (both in NOK)

= 0.93 ÷ -0.47

-1.99x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • IDEX Biometrics is loss making, we can't compare its value to the GB Electronic industry average.
  • IDEX Biometrics is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does IDEX Biometrics's expected growth come at a high price?
Raw Data
BATS-CHIXE:IDEXO PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.99x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United Kingdom of Great Britain and Northern Ireland Electronic Industry PEG Ratio Median Figure of 11 Publicly-Listed Electronic Companies 1.08x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 518 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for IDEX Biometrics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on IDEX Biometrics's assets?
Raw Data
BATS-CHIXE:IDEXO PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in NOK NOK0.22
OB:IDEX Share Price * OB (2020-04-07) in NOK NOK0.93
United Kingdom of Great Britain and Northern Ireland Electronic Industry PB Ratio Median Figure of 33 Publicly-Listed Electronic Companies 1.89x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.13x
BATS-CHIXE:IDEXO PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OB:IDEX Share Price ÷ Book Value per Share (both in NOK)

= 0.93 ÷ 0.22

4.26x

* Primary Listing of IDEX Biometrics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • IDEX Biometrics is overvalued based on assets compared to the GB Electronic industry average.
X
Value checks
We assess IDEX Biometrics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Electronic industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Electronic industry average (and greater than 0)? (1 check)
  5. IDEX Biometrics has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

IDEXO Future Performance

 How is IDEX Biometrics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IDEX Biometrics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.4%
Expected Electronic industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is IDEX Biometrics expected to grow at an attractive rate?
  • Unable to compare IDEX Biometrics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare IDEX Biometrics's earnings growth to the United Kingdom of Great Britain and Northern Ireland market average as no estimate data is available.
  • Unable to compare IDEX Biometrics's revenue growth to the United Kingdom of Great Britain and Northern Ireland market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:IDEXO Future Growth Rates Data Sources
Data Point Source Value (per year)
United Kingdom of Great Britain and Northern Ireland Electronic Industry Earnings Growth Rate Market Cap Weighted Average 9.4%
United Kingdom of Great Britain and Northern Ireland Electronic Industry Revenue Growth Rate Market Cap Weighted Average 4.1%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.6%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:IDEXO Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in NOK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:IDEXO Future Estimates Data
Date (Data in NOK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
BATS-CHIXE:IDEXO Past Financials Data
Date (Data in NOK Millions) Revenue Cash Flow Net Income *
2019-12-31 4 -243 -285
2019-09-30 3 -236 -263
2019-06-30 3 -233 -257
2019-03-31 3 -226 -257
2018-12-31 4 -214 -246
2018-09-30 6 -218 -248
2018-06-30 8 -231 -251
2018-03-31 13 -257 -252
2017-12-31 17 -235 -255
2017-09-30 27 -227 -235
2017-06-30 32 -206 -230
2017-03-31 42 -185 -209

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if IDEX Biometrics is high growth as no earnings estimate data is available.
  • Unable to determine if IDEX Biometrics is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:IDEXO Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from IDEX Biometrics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:IDEXO Future Estimates Data
Date (Data in NOK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
BATS-CHIXE:IDEXO Past Financials Data
Date (Data in NOK Millions) EPS *
2019-12-31 -0.47
2019-09-30 -0.45
2019-06-30 -0.45
2019-03-31 -0.46
2018-12-31 -0.45
2018-09-30 -0.46
2018-06-30 -0.46
2018-03-31 -0.46
2017-12-31 -0.47
2017-09-30 -0.44
2017-06-30 -0.43
2017-03-31 -0.40

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if IDEX Biometrics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine IDEX Biometrics's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. IDEX Biometrics's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Tech companies here
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess IDEX Biometrics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
IDEX Biometrics has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

IDEXO Past Performance

  How has IDEX Biometrics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare IDEX Biometrics's growth in the last year to its industry (Electronic).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • IDEX Biometrics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare IDEX Biometrics's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare IDEX Biometrics's 1-year growth to the GB Electronic industry average as it is not currently profitable.
Earnings and Revenue History
IDEX Biometrics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from IDEX Biometrics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:IDEXO Past Revenue, Cash Flow and Net Income Data
Date (Data in NOK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 3.72 -285.34 190.59 38.59
2019-09-30 3.44 -262.91 175.28 36.92
2019-06-30 3.20 -256.98 169.44 37.66
2019-03-31 3.12 -256.93 168.00 44.91
2018-12-31 3.59 -246.10 160.98 45.85
2018-09-30 5.68 -247.72 141.28 44.66
2018-06-30 8.11 -251.13 142.49 51.74
2018-03-31 12.54 -251.87 142.09 51.99
2017-12-31 17.47 -255.49 139.85 56.26
2017-09-30 27.48 -235.16 134.28 58.91
2017-06-30 32.38 -230.15 126.95 65.48
2017-03-31 41.77 -209.14 104.56 70.89
2016-12-31 38.56 -203.25 90.38 81.36
2016-09-30 26.26 -233.98 89.52 105.80
2016-06-30 17.94 -228.98 73.35 107.09
2016-03-31 3.86 -233.61 74.01 111.58
2015-12-31 0.35 -228.83 76.30 102.57
2015-09-30 1.40 -195.74 78.12 83.82
2015-06-30 1.49 -169.06 73.56 72.78
2015-03-31 1.47 -143.12 67.26 57.19
2014-12-31 1.51 -123.11 54.40 51.30
2014-09-30 0.69 -104.64 43.84 40.94
2014-06-30 1.04 -96.16 37.21 32.35
2014-03-31 1.83 -84.79 30.92 25.87
2013-12-31 2.53 -65.01 24.65 17.34
2013-09-30 3.19 -45.87 16.63 10.99
2013-06-30 4.00 -34.66 15.65 8.75

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if IDEX Biometrics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if IDEX Biometrics has efficiently used its assets last year compared to the GB Electronic industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if IDEX Biometrics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess IDEX Biometrics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Electronic industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
IDEX Biometrics has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

IDEXO Health

 How is IDEX Biometrics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up IDEX Biometrics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • IDEX Biometrics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • IDEX Biometrics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of IDEX Biometrics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • IDEX Biometrics has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from IDEX Biometrics Company Filings, last reported 3 months ago.

BATS-CHIXE:IDEXO Past Debt and Equity Data
Date (Data in NOK Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 156.41 0.00 124.03
2019-09-30 149.22 0.00 96.94
2019-06-30 208.68 0.00 155.09
2019-03-31 273.31 0.00 224.92
2018-12-31 123.24 0.00 83.44
2018-09-30 173.05 0.00 130.47
2018-06-30 227.67 0.00 189.89
2018-03-31 284.47 0.00 244.78
2017-12-31 337.06 0.00 301.46
2017-09-30 397.54 0.00 359.36
2017-06-30 457.27 0.00 428.38
2017-03-31 515.85 0.00 506.85
2016-12-31 562.37 0.00 531.77
2016-09-30 601.49 0.00 579.38
2016-06-30 656.53 0.00 623.39
2016-03-31 698.74 0.00 682.74
2015-12-31 749.68 0.00 760.60
2015-09-30 400.80 0.00 381.95
2015-06-30 434.00 0.00 431.12
2015-03-31 202.85 0.00 181.00
2014-12-31 243.35 0.00 226.75
2014-09-30 283.31 0.00 261.42
2014-06-30 307.71 0.00 294.67
2014-03-31 327.42 0.00 342.51
2013-12-31 49.88 0.00 45.34
2013-09-30 67.39 0.00 60.48
2013-06-30 30.63 0.00 36.57
  • IDEX Biometrics has no debt.
  • IDEX Biometrics has not taken on any debt in the past 5 years.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • IDEX Biometrics has less than a year of cash runway based on current free cash flow.
  • IDEX Biometrics has less than a year of cash runway if free cash flow continues to grow at historical rates of 15.2% each year.
X
Financial health checks
We assess IDEX Biometrics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. IDEX Biometrics has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

IDEXO Dividends

 What is IDEX Biometrics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from IDEX Biometrics dividends.
If you bought NOK2,000 of IDEX Biometrics shares you are expected to receive NOK0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate IDEX Biometrics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate IDEX Biometrics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:IDEXO Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Electronic Industry Average Dividend Yield Market Cap Weighted Average of 16 Stocks 1.8%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.5%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.5%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 6.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:IDEXO Future Dividends Estimate Data
Date (Data in NOK) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as IDEX Biometrics has not reported any payouts.
  • Unable to verify if IDEX Biometrics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of IDEX Biometrics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as IDEX Biometrics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess IDEX Biometrics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can IDEX Biometrics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. IDEX Biometrics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

IDEXO Management

 What is the CEO of IDEX Biometrics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Vince Graziani
TENURE AS CEO 0.2 years
CEO Bio

Mr. Vincent Graziani, also known as Vince, has been Chief Executive Officer of Sand 9 Inc. since February 2010 and serves as its President. Mr. Graziani serves as Chief Executive Officer at IDEX Biometrics ASA since January 27, 2020. Mr. Graziani served as Chief Executive Officer of VBrick Systems, Inc. from August 7, 2007 to January 2010. He served as the Chief Executive Officer, President and Senior Vice President of Operations of Sandburst Corporation. He oversaw product introductions and raised four rounds of venture financing of Sandburst. Mr. Graziani helped establish Intel as a serious contender in the communications and internetworking semiconductor space. He was responsible for managing all aspects of the technical sales process from demand creation and design wins to technical customer support. Mr. Graziani spent four years as a hardware design engineer. He has focused his career on technical sales and marketing in the communications semiconductor industry. He served as a Director of VBrick Systems, Inc. He serves as a Director of Sand 9, Inc. Mr. Graziani served as a Senior Director of Business Development and Strategic Alliances of Broadcom Corporation. He served as a Director of Sandburst Corporation. He served as Director of Siemens Semiconductor and Level One Communications. He holds a Master's degree in communications and signal processing from Northeastern University.

CEO Compensation
  • Insufficient data for Vince to compare compensation growth.
  • Insufficient data for Vince to establish whether their remuneration is reasonable compared to companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the IDEX Biometrics management team in years:

1.1
Average Tenure
53
Average Age
  • The average tenure for the IDEX Biometrics management team is less than 2 years, this suggests a new team.
Management Team

Henrik Knudtzon

TITLE
COMPENSATION
NOK5M
AGE
39
TENURE
0.8 yrs

Stan Swearingen

TITLE
Senior Vice President of Strategy & Advanced Technology
COMPENSATION
NOK9M
AGE
59
TENURE
3.5 yrs

Fred Benkley

TITLE
Chief Innovation Officer
COMPENSATION
NOK4M
AGE
62
TENURE
1.1 yrs

Vince Graziani

TITLE
Chief Executive Officer
TENURE
0.2 yrs

Svein Mathiassen

TITLE
Co-Founder
TENURE
23.8 yrs

Derek D'Antilio

TITLE
Chief Financial Officer
TENURE
0.8 yrs

Paul Taylor

TITLE
Vice President of Operations & Program Management

Anthony Eaton

TITLE
Chief Technology Officer
AGE
47
TENURE
1.1 yrs

Stuart Hunt

TITLE
Head of Investor Relations & Communications

David Orme

TITLE
Senior VP of Sales Marketing
TENURE
1.8 yrs
Board of Directors Tenure

Average tenure and age of the IDEX Biometrics board of directors in years:

5.5
Average Tenure
60
Average Age
  • The tenure for the IDEX Biometrics board of directors is about average.
Board of Directors

Morten Opstad

TITLE
Chairman of the Board
AGE
66
TENURE
23.1 yrs

Larry Ciaccia

TITLE
Chairman of the Strategy Advisory Council & Deputy Chairman of Board
AGE
60
TENURE
1.3 yrs

Hanne Høvding

TITLE
Director
AGE
65
TENURE
12.3 yrs

Deborah Davis

TITLE
Director
AGE
56
TENURE
5.3 yrs

Michael Barrett

TITLE
Member of Strategy Advisory Council
TENURE
5.8 yrs

Steve Skaggs

TITLE
Director
AGE
56
TENURE
0.9 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by IDEX Biometrics individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (NOK) Value (NOK)
28. Feb 20 Buy Derek D'Antilio Individual 27. Feb 20 27. Feb 20 250,000 NOK0.73 NOK182,500
15. Nov 19 Buy Guido Bertocci Individual 15. Nov 19 15. Nov 19 725,000 NOK0.79 NOK572,905
15. Nov 19 Buy Guido Bertocci Individual 14. Nov 19 14. Nov 19 500,000 NOK0.78 NOK390,095
30. Aug 19 Buy Stephen Skaggs Individual 29. Aug 19 29. Aug 19 50,000 NOK2.21 NOK110,725
29. Aug 19 Buy Stephen Skaggs Individual 28. Aug 19 28. Aug 19 50,000 NOK2.12 NOK106,222
28. Aug 19 Buy Stephen Skaggs Individual 27. Aug 19 27. Aug 19 50,000 NOK1.91 NOK95,743
27. Aug 19 Buy Derek D'Antilio Individual 26. Aug 19 26. Aug 19 50,000 NOK1.86 NOK93,000
27. Aug 19 Buy Stephen Skaggs Individual 26. Aug 19 26. Aug 19 50,000 NOK1.78 NOK89,132
26. Aug 19 Buy Stephen Skaggs Individual 23. Aug 19 23. Aug 19 50,000 NOK1.84 NOK92,070
23. Aug 19 Buy Stephen Skaggs Individual 22. Aug 19 22. Aug 19 50,000 NOK1.81 NOK90,720
22. Aug 19 Buy Stephen Skaggs Individual 21. Aug 19 21. Aug 19 50,000 NOK1.60 NOK79,779
22. Aug 19 Buy Derek D'Antilio Individual 22. Aug 19 22. Aug 19 50,000 NOK1.78 NOK89,000
X
Management checks
We assess IDEX Biometrics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. IDEX Biometrics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

IDEXO News

Simply Wall St News

IDEXO Company Info

Description

IDEX Biometrics ASA develops and sells fingerprint imaging and recognition technology in Europe, the Middle East, Africa, the Americas, and Asia. The company offers IDEX Biometrics for the biometrics smart card market, including biometric fingerprint sensors for use in dual interface, contactless only, and contact only smart cards; biometric fingerprint modules for contact based smart cards; and on-card enrollment solutions for remote in-person enrollment. It provides fingerprint sensor products and solutions for use across various device types, such as payments, identification, access control, healthcare, and the Internet of Things. IDEX Biometrics ASA has collaboration agreements with Chutian Dragon Co., Ltd, Tongxin Microelectronics Co., Ltd., Exelsecu, and XH Smart Tech, as well as a partnership with Goldpac Group Ltd. to introduce dual-interface biometric smart cards. The company was formerly known as Idex ASA and changed its name to IDEX Biometrics ASA in May 2019. The company was founded in 1996 and is headquartered in Bærum, Norway.

Details
Name: IDEX Biometrics ASA
IDEXO
Exchange: BATS-CHIXE
Founded: 1996
NOK666,293,543
717,988,732
Website: http://www.idexbiometrics.com
Address: IDEX Biometrics ASA
Martin Linges Vei 25,
Fornebu,
Bærum,
Akershus, 1364,
Norway
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OB IDEX Ordinary Shares Oslo Bors NO NOK 27. Nov 1997
OTCPK IDXA.F Ordinary Shares Pink Sheets LLC US USD 27. Nov 1997
DB I8X Ordinary Shares Deutsche Boerse AG DE EUR 27. Nov 1997
LSE 0MTP Ordinary Shares London Stock Exchange GB NOK 27. Nov 1997
BATS-CHIXE IDEXO Ordinary Shares BATS 'Chi-X Europe' GB NOK 27. Nov 1997
Number of employees
Current staff
Staff numbers
100
IDEX Biometrics employees.
Industry
Electronic Components
Tech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 20:14
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2019/02/27
Last earnings filing: 2020/02/27
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.